SEATTLE, July 16, 2018 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, including the Carnation Ambulatory Monitor (“CAM™”), the world’s first P-wave centric™ ambulatory cardiac monitor and arrhythmia detection device, announced today it has raised additional growth capital from its existing equity investors, including SV Health Investors (“SVHI”), Health Enterprise Partners, and Ascension Ventures. The growth capital will be used to expand BardyDx’s sales force and monitoring services, advance research and development programs, and accelerate development of artificial intelligence diagnostic capabilities. Read More
When Steven Wilkinson began his job as senior director of total rewards at Serta Simmons Bedding four years ago, finding better healthcare ranked high on his priority list.
“I was looking for a way to engage our employees on their health and well-being,” he says. “We did some surveys and focus groups with employees and found that unless we could come to them, bring the health checkup to them, most were not going to get the preventive care they needed — even though it’s provided in their health plan.” Read More
HEP III will invest in next generation of healthcare information technology and services companies
NEW YORK, July 9, 2018 /PRNewswire/ — Backed by some of the largest healthcare organizations in the country, Health Enterprise Partners (“HEP”) today announced the final close of its oversubscribed third fund, reaching its hard cap and raising $188 million. Read More
Combined resources help broaden healthcare footprint of both organizations while deepening analytics capabilities
WEST HARTFORD, Conn., July 3, 2018 /PRNewswire/ — SCIO Health Analytics® announced that it completed its sale to EXLService Holdings. Inc. (NASDAQ: EXLS), a leading operations management and analytics company. SCIO’s growth over the last 10 years has been driven by its proven leadership in strategy and innovation around the use of big data and analytics to help payers, providers, and life sciences organizations improve revenue, quality, and operations while solving some of healthcare’s greatest challenges.
“From its founding, SCIO has been dedicated to driving positive change by helping our clients effectively manage critical issues such as the transition to value-based care,” said Siva Namasivayam, co-founder and chief executive officer, SCIO. “We are excited to combine our analytics capabilities and deep healthcare expertise with those of EXL, who is already a world-class global services provider and recognized leader in healthcare analytics.” Read More
SAN FRANCISCO, June 21, 2018 /PRNewswire/ — Wildflower Health, a leading mobile health software company, today announced it has acquired the Circle Women’s Health Platform, a mobile health technology incubated by Providence St. Joseph Health (PSJH), the nation’s third-largest nonprofit health system. As part of the transaction, PSJH has signed an enterprise-wide commercial agreement with Wildflower. Providence Ventures will also participate in Wildflower’s recently announced Series C financing led by Health Enterprise Partners, with participation by existing investors Hatteras Venture Partners and Echo Health Ventures.
KANSAS CITY, Mo. – Their jobs put them on the front lines of danger and often times tragedy. Through the Valor Recovery Program (VRP), veterans, first responders and active duty military members are facing their fears in a healthy way.
Kansas City, Kansas has dealt with officer shootings before. Two KCK officers were shot and killed within less than three months in 2016.
“It’s tough. It brings back a lot of memories, a lot of triggers that you wouldn’t think about normally,” said KCK Police Chief Terry Zeigler. Read More
WEST HARTFORD, Conn., June 13, 2018 /PRNewswire/ — SCIO Health Analytics announced today that for the second consecutive year it has earned placement in the distinguished Healthcare Informatics 100 list of top U.S. healthcare information technology software vendors ranked by annual revenues. SCIO was ranked at number 95.
For more than two decades, Healthcare Informatics has published the Healthcare Informatics 100, which brings to the healthcare information technology audience key data and information on the leading software vendor companies. No other publication or organization publishes such a comprehensive set of data and information on the leading vendors in the U.S. healthcare information technology industry. Read More
The American Heart Journal has published the results of a head-to-head comparison of two patch-based arrhythmia monitoring systems. The study, “Comparison of two ambulatory patch ECG monitors: The benefit of the P-wave and signal clarity” concluded that the BardyDx CAM singlechannel patch ambulatory ECG monitor (AEM), designed specifically to enhance P-wave detection, identified significantly more arrhythmias and resulted in better, more informed clinical decision-making over the iRhythm Zio XT patch.
In the prospective time-paired comparative study led by electrophysiologist Robert Rho, 30 patients simultaneously wore a pectorally-placed arrhythmia monitoring patch (iRhythm Technologies, Zio XT patch) and a P-wave centric arrhythmia monitoring patch (Bardy Diagnostics, CAM patch) placed over the sternum with the intent of recording for seven days. At the end of the monitoring period, the patches were removed at the same visit. The outcome measures were to compare diagnostic yield, ECG signal clarity, ease of use and comfort, and, importantly, an assessment of differences in clinical decision-making based upon each device’s rhythm diagnosis. Read More
NEW YORK — June 12, 2018 — Medidata (NASDAQ: MDSO) today announced that it has entered into a definitive agreement to acquire SHYFT Analytics, bringing the leading platform for clinical development together with the leading platform for commercial and real-world data analytics.
The combined platform seamlessly delivers market-leading applications, services, and proven data science capabilities, powered by the largest global pool of research data, companies’ own CRM data, 3rd party commercial data, and real-world data sources.
Pharmaceutical, biotech, and medical device companies now have an unprecedented ability to manage and optimize value across the clinical and commercial continuum. Read More